Myeloma approval

November 25, 2015

The US FDA has granted approval to Ninlaro (ixazomib), made by Takeda, which is the “first and only oral proteasome inhibitor” indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma. Ninlaro is administered as a once weekly tablet, with the coming just months after Takeda submitted its new drug application to the FDA in Jul and subsequently being granted Priority review status “reflecting the profound and continuing unmet need for new treatments”.

The above article was sent to subscribers in Pharmacy Daily's issue from 25 Nov 15
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Nov 15

Other recent headlines

Ozempic reduces cancer risk
Friday | Aug 22 2025
PEOPLE with obesity who take glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reduced risk of cancer compared to those not using those medications, according to US research published today in JAMA Oncology.

No business like Snow Business
Friday | Aug 22 2025
PHARMACISTS from across Australia recently came together for the Pharmacy Snow Business Conference at Mt Buller, sharing a passion for skiing alongside their commitment to professional development.

Pharmx delivers strong FY25
Thursday | Aug 21 2025
PHARMX Technologies yesterday announced strong results for the financial year ending 30 Jun 2025, with total revenues of $7.5 million, up 13% on the previous corresponding period.

SEARCH PHARMACY DAILY

Featured video
MORE VIDEOS

Recent issues

PD for Fri 22 Aug 2025
PD for Thu 21 Aug 2025
PD for Wed 20 Aug 2025
PD for Tue 19 Aug 2025
PD for Mon 18 Aug 2025
SEE MORE ISSUES

INDUSTRY JOB VACANCIES

Pharmacist in Charge – SA
Pharmacist Manager – WA
Compounding Pharmacist – Melbourne
Pharmacist in Charge – QLD North
Pharmacist – Sydney North
SEE MORE JOBS

Pharmacy Daily is Australia's favourite online publication dedicated to the pharmacy industry. The publication launched in March 2007 and is distributed every day by email to pharmacists across the country.

PHARMACY DAILY NEWS
Headlines

Jobs

New Products

Events Calendar

FEEDS
News Items RSS feed

PD Issues RSS feed

All content RSS feed

Content & Media
Pharmacy Daily TV

OUR SITES
Sitemap

Travel Daily

Travel Bulletin

Cruise Weekly

Business Events News

Pharmacy Daily

ADVERTISE WITH US
Advertise in Pharmacy Daily

Privacy

ADMIN
Log in

SUBSCRIBE
Sign up for FREE

Subscription Information

"Water, air, and cleanness are the chief articles in my pharmacy." - Napoleon Bonaparte

Copyright © 2025 Pharmacy Daily

Subscribe to Pharmacy Daily now!

FREE Pharmacy Daily subscription - never miss another story!

Name*
First Last
Email*

Profession
Company

Address
City State / Province / Region ZIP / Postal Code Country

By submitting this form I hereby certify that I understand that Pharmacy Daily is a publication for health professionals.
Email
This field is for validation purposes and should be left unchanged.

to top

Pharmacy Daily | Myeloma approval

Myeloma approval

Other recent headlines

Ozempic reduces cancer risk

No business like Snow Business

Pharmx delivers strong FY25

SEARCH PHARMACY DAILY

Featured video

Recent issues

INDUSTRY JOB VACANCIES